ArticlePloS one2019

Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin.

Maria Agudelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.